Clinical Trials Logo

Filter by:
NCT ID: NCT04796649 Not yet recruiting - Diabetic Foot Ulcer Clinical Trials

Laser Therapy for At-Home Treatment of DIabetic Foot Ulcers (LLL&DIAB-03)

Start date: May 15, 2022
Phase: N/A
Study type: Interventional

The global prevalence of diabetes is on the rise and with it increase in prevalence of diabetic foot ulcers (DFU). These recalcitrant wounds are difficult to manage and pose a heavy economic burden. Photobiomodulation (low-level laser) is used for acceleration of wound healing. The current study is designed to evaluate the effectiveness of B-cure laser, a home-use low-level laser device, for acceleration of diabetic foot ulcer healing over standard treatment

NCT ID: NCT04779762 Not yet recruiting - Crohn Disease Clinical Trials

Stelara and Diet Trial for Crohn"s Disease

Start date: January 2022
Phase: N/A
Study type: Interventional

Dietary therapy involving the Crohn's disease exclusion diet (CDED) is an evolving strategy to target the microbiome and innate immunity in order to reduce inflammation and promote healing. The goal of the current pilot study is to evaluate the added benefit of treatment with Ustekinumab combined with CDED in anti TNF exposed patients compared to treatment with Ustekinumab alone in term of achieving remission.

NCT ID: NCT04763486 Not yet recruiting - Puerperal Infection Clinical Trials

Prophylactic Antibiotic After Perineal Tear

PATPET
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Current World Health Organization guidelines recommend routine antibiotic prophylaxis for women with perineal tear 3rd and 4th degree but not for 2nd degree because of insufficient evidence of effectiveness. The investigators aimed to investigate whether antibiotic prophylaxis prevented maternal infection after the first and second perineal tear after vaginal birth.

NCT ID: NCT04668547 Not yet recruiting - Clinical trials for Induced Abortion and Complications of Termination of Pregnancy

Embryoscopic Evacuation for Induced Abortion

Start date: January 2021
Phase: N/A
Study type: Interventional

The investigators intend to assess if hysteroscopic evacuation of gestational tissue, is possible as a tool for early induced abortion with a hysteroscopic morcellator rather than with a traditional dilation and curettage procedure. The investigators hypothesize that induced abortion under vision with hysteroscopic guidance may provide benefits over the traditional "blind" procedure

NCT ID: NCT04664790 Not yet recruiting - FASD Clinical Trials

Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

Fetal Alcohol Spectrum Disorder (FASD) describes a wide range of adverse physical, behavioral and cognitive effects resulting from prenatal alcohol exposure (PAE) during embryonic and fetal development. A number of clinical studies have presented evidence regarding the physiological effects of HBOT on metabolically dysfunctional brain regions that might be related to FASD. The aim of the study is to compare the effect of HBOT vs. neurocognitive training on neurobehavioral function in FASD.

NCT ID: NCT04660266 Not yet recruiting - Clinical trials for Ultrasound Therapy; Complications

Accuracy of Ultrasound Exam, Including Doppler and Elastography, in the Diagnosis of VOD, Following Bone Marrow Transplantation

Start date: December 2020
Phase: N/A
Study type: Interventional

The purpose of the study: Validation of the use of intentional ultrasound examination, which includes Doppler and elastography for the diagnosis of obstructive venous disease of the liver within 21 days after bone marrow transplantation. Protocol: Patients who are planned for a bone marrow transplantaion will be recruited for the study by the staff of the Transplant Department. Inclusion criteria: Patients over the age of 18 before a bone marrow transplantation. Eligibility criteria: Transplanted under 18 years of age Research protocol: After informed consent, patients will undergo an ultrasound examination before the transplant. After 14 days and again after 21 days patients will undergo two more US exams, If there is a change in their clinical condition the patients will undergo additional examination accordingly. At the same time on the 14th and 21st day a clinical evaluation will be performed by the clinical physician in the transplant department based on clinical criteria of European Blood and Brain Transplant Association (EBMT). The results of the clinical evaluation and blood test results will be collected. Patients will be divided into two groups: - Control group: Patients who did not develop VOD( veno occlusive disease ) during 21 days. - Study group: Patients who developed VOD during 21 days. All ultrasound examination data will be compared between the two groups in In addition will be collected: - Demographics - age, sex. - Background diseases including heart and liver diseases. - Basic disease as a transplantation cause. All data will be collected anonymously and coded separately.

NCT ID: NCT04599387 Not yet recruiting - Clinical trials for Pulmonary Disease, Chronic Obstructive

Remote Prescribed and Monitored Exercise Program After Pulmonary Rehabilitation in Individuals With Chronic Lung Disease

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

Remote Prescribed and Monitored Exercise Program After Pulmonary Rehabilitation in Individuals with Chronic Lung Disease

NCT ID: NCT04592497 Not yet recruiting - Atrial Fibrillation Clinical Trials

Evaluation of the Safety and Performance of the Very High Power-Short Duration QDOT

Start date: October 15, 2020
Phase: N/A
Study type: Interventional

The aim of the present study is to compare the safety and short-term performance between THERMOCOOL SMARTTOUCH SF-5D QDOT system used with fast ablation mode and the standard Thermocool Smartouch SF in treatment of patients with atrial fibrillation (AF).

NCT ID: NCT04583137 Not yet recruiting - Anesthesia, Local Clinical Trials

Buffered vs Plain Lidocaine for Local Nasal Anesthesia

Start date: November 1, 2020
Phase: Early Phase 1
Study type: Interventional

Transnasal Fiberoptic Laryngoscopy (TFL) is a common procedure in the otolaryngology clinic for the examination of vocal cord appearance and function, inspection and follow up of benign and malignant lesions, and investigating foreign body ingestion. There are many forms for applying preprocedural local nasal anesthesia such as atomizers, nebulizers, spray, soaked pads, or local anesthetic gel application. This study compares the effect of buffered versus plain lidocaine for local nasal anesthesia.

NCT ID: NCT04558268 Not yet recruiting - Clinical trials for Recurrent Miscarriage

Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss

Start date: December 2020
Phase: Phase 2/Phase 3
Study type: Interventional

For many years there is a lack of large randomized controlled trials that study the effect of low dose prednisone in women with RPL and thus the evidence of a probable efficacy of prednisone in RPL women remains limited and unclear. As the ESHRE recommended in 2018 (2) we aim to assess the effect of such treatment in a large trial that includes unexplained and abnormal autoimmune profile RPL patients. we also aim to assess the side effects of the treatment in RPL pregnant women.